Small Molecule Nitazoxanide Inhibits Osteogenic Differentiation and Promotes Adipogenic Differentiation of Bone

Abstract

Insights

Nitazoxanide (NTZ) suppresses bone formation and promotes fat formation in stem cells by inhibiting the Wnt/β-catenin pathway. This suggests NTZ may negatively impact bone health.

Area of Science:

  • Stem cell biology
  • Pharmacology
  • Bone biology

Background:

  • Bone marrow mesenchymal stem cells (BMSCs) differentiate into osteoblasts (bone-forming cells) or adipocytes (fat-forming cells).
  • The balance between osteogenic and adipogenic differentiation is crucial for maintaining bone homeostasis.
  • Nitazoxanide (NTZ) is a small molecule with known antiparasitic and antiviral properties.

Purpose of the Study:

  • To investigate the effect of nitazoxanide (NTZ) on the osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells (BMSCs).

Main Methods:

  • Cell proliferation was assessed using the Cell Counting Kit-8 assay.
  • Gene and protein expression of osteogenic and adipogenic markers were analyzed by qRT-PCR and Western blot.
  • Osteogenesis was evaluated using alkaline phosphatase (ALP) staining and activity assays, and Alizarin Red S (ARS) staining.
  • Adipogenesis was assessed using Oil Red O (ORO) staining.

Main Results:

  • NTZ significantly suppressed osteogenic differentiation of BMSCs.
  • NTZ promoted adipogenic differentiation of BMSCs.
  • NTZ inhibited the Wnt/β-catenin signaling pathway, which was reversed by lithium chloride, a Wnt/β-catenin activator.

Conclusions:

  • NTZ influences BMSC differentiation towards adipogenesis and away from osteogenesis.
  • The Wnt/β-catenin signaling pathway is involved in NTZ's effects on BMSC differentiation.
  • NTZ may adversely affect bone homeostasis due to its impact on BMSC differentiation.